Unveiling the Molecular Mechanism of Trastuzumab Resistance in SKBR3 and BT474 Cell Lines for HER2 Positive Breast Cancer

Unveiling the Molecular Mechanism of Trastuzumab Resistance in SKBR3 and BT474 Cell Lines for HER2 Positive Breast Cancer

HER2-positive breast cancer is one of the most prevalent forms of cancer among women worldwide. Generally, the molecular characteristics of this breast cancer include activation of human epidermal growth factor receptor-2 (HER2) and hormone receptor activation. HER2-positive is associated with a hig...

Full description

Bibliographic Details
Main Authors: Anna Kokot, Sachin Gadakh, Indrajit Saha, Ewa Gajda, Michał Łaźniewski, Somnath Rakshit, Kaustav Sengupta, Ayatullah Faruk Mollah, Michał Denkiewicz, Katarzyna Górczak, Jürgen Claesen, Tomasz Burzykowski, Dariusz Plewczynski
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Current Issues in Molecular Biology
Subjects:
microRNA
microarray
HER2
breast cancer
drug resistance
Online Access:https://www.mdpi.com/1467-3045/46/3/171

Internet

https://www.mdpi.com/1467-3045/46/3/171

Similar Items